Stefan Willemsen is a member of Sepsis Alliance Advisory Board and an Executive leader with over 20 years of experience in the IVD and Life Science Industries. Stefan currently is CEO of Covid Apollo, a consortium of healthcare-oriented investment funds led by RA Capital that funded the X-Prize Foundation Covid19 fast diagnostics challenge and seeks to invest in technologies and companies that accelerate. Simplify and democratize Covid19 and other infectious disease testing. Before, Stefan was President and CEO of bioMérieux Inc., from 2014 until 2020 leading all of Biomérieux operations in the US and the Americas region and also serving as a board member of AdvamedDx. Stefan has also worked at Roche Diagnostics as VP Head of Business Development and Program Management for custom PCR Assays. He is a lawyer by training with degrees from the University of Bonn in Germany and the George Washington University in US and an Alumni of the 2013 INSEAD Advanced Management Program.